Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Erdem, Cubukcu"'
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın, Ali Gökyer, Ahmet Kücükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karatas, Hacer Demir, Ayse Irem Yasin, Adem Deligonul, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gülhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5195-5205 (2024)
Background: This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the failure of at least one anti-vascular endothelial growth factor (VEGF) agent in pati
Externí odkaz:
https://doaj.org/article/e3b91b5047204acf948136cd657f8dec
Autor:
Ibrahim Boga, Sebnem Ozemri Sag, Nilgun Duman, Sevda Yesim Ozdemir, Mahmut Cerkez Ergoren, Kubilay Dalci, Cem Mujde, Cem Kaan Parsak, Cagla Rencuzogullari, Ozge Sonmezler, Orcun Yalav, Adem Alemdar, Lamiya Aliyeva, Ozlem Bozkurt, Sibel Cetintas, Erdem Cubukcu, Adem Deligonul, Berkcan Dogan, Cemre Ornek Erguzeloglu, Turkkan Evrensel, Sehsuvar Gokgoz, Kazim Senol, Sahsine Tolunay, Esra Akyurek, Neslihan Basgoz, Nuriye Gökçe, Bilge Dundar, Figen Ozturk, Duygu Taskin, Mercan Demirtas, Murat Cag, Omer Diker, Polat Olgun, Sevcan Tug Bozdogan, Munis Dundar, Atil Bisgin, Sehime Gulsun Temel
Publikováno v:
European Journal of Breast Health, Vol 19, Iss 3, Pp 235-252 (2023)
Objective:Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2,
Externí odkaz:
https://doaj.org/article/a71c390801df4f9498bd73b6b92a7cb8
Autor:
Ahmet Bilgehan Şahin, Erdem Cubukcu, Birol Ocak, Adem Deligonul, Sibel Oyucu Orhan, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz, Sibel Cetintas, Gorkem Yarbas, Kazım Senol, Mehmet Refik Goktug, Zeki Burak Yanasma, Ulviyya Hasanzade, Turkkan Evrensel
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker, Pan-Immune-Inflammation-Value (PIV) integrates different peripheral blood cell subpo
Externí odkaz:
https://doaj.org/article/7b6143d575cd46e1a0f433bfca8c57dc
Correlation between Ubiquitin E3 Ligases (SIAHs) and Heat Shock Protein 90 in Breast Cancer Patients
Autor:
Leila Sabour Takanlou, Gulsah Cecener, Maryam Sabour Takanlou, Hulya Ozturk Nazlioglu, Havva Tezcan Unlu, Ozgen Isik, Unal Egeli, Berrin Tunca, Erdem Cubukcu, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz
Publikováno v:
Iranian Journal of Public Health, Vol 51, Iss 8 (2022)
Background: Breast cancer is a heterogeneous disease and differences in the expression levels of the ER, PR, and HER2 the triplet of established biomarkers used for clinical decision-making have been reported among breast cancer patients. Furthermore
Externí odkaz:
https://doaj.org/article/a7e0c5d247564e079a36c1c42e000b3d
Autor:
Sibel Oyucu Orhan, Ahmet Bilgehan Sahin, Erdem Cubukcu, Adem Deligonul, Birol Ocak, Bedrettin Orhan, Turkkan Evrensel
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 6 (2021)
Kaposi sarcoma is a rare disease and there is a gap in the literature about which chemotherapeutics should be applied, especially for the classical type. We aimed to present our institutional data on the demographic characteristics, treatment, and tr
Externí odkaz:
https://doaj.org/article/591e8ec5dbdd448c988d0d361de9a31f
Autor:
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Cakar, Abdallah T. M. Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gumus, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Publikováno v:
Acta Oncologica. 62:381-390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::512cb58c96f66e66f4b3feed70d33ed8
https://doi.org/10.1080/0284186x.2023.2202330
https://doi.org/10.1080/0284186x.2023.2202330
Autor:
Deligonul Adem, Serkan Yazici, Mine Ozsen, Sibel Kahraman Cetintas, Ulviye Yalcinkaya, Ahmet Bilgehan Şahin, Ozgur Tanrıverdi, Sibel Oyucu Orhan, Birol Ocak, Erdem Cubukcu, Ramazan Kahveci, Turkkan Evrensel
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 2 (2021)
Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue sarcoma that originates from the dermis or subcutaneous tissue in the skin. While its prognosis is generally favorable, disease recurrence is relatively frequent. Because morbidity aft
Externí odkaz:
https://doaj.org/article/d6e4c7ade56c427085004997390e5f9f
Autor:
Birol Ocak, Fatma Öz Atalay, Ahmet Bilgehan Sahin, Mine Ozsen, Bahar Dakiki, Seray Türe, Merve Mesohorli, Hikmet Utku Odman, Özgür Tanrıverdi, Gökhan Ocakoğlu, Mehmet Bayrak, Hakan Ozan, Candan Demiröz, Seda Sali, Sibel Oyucu Orhan, Adem Deligönül, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Biomolecules & Biomedicine, Vol 21, Iss 5 (2021)
Endometrial endometrioid carcinoma (EEC) represents approximately 75-80% of endometrial carcinoma cases. Three hundred and thirty-six patients with EEC followed-up in the authors’ medical center between 2010 and 2018 were included in our study. Two
Externí odkaz:
https://doaj.org/article/db46d62a731e4306b405413e32d48f98
Publikováno v:
Molecular Biology Reports. 50:3489-3492
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c665456975c5f011d34024c4aa0256c5
https://doi.org/10.1007/s11033-023-08296-6
https://doi.org/10.1007/s11033-023-08296-6
Autor:
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Burcin Cakan Demirel, Omer Acar, Sercan Aksoy, Naziyet Kose Baytemur, Elif Sahin, Devrim Cabuk, Gul Basaran, Semra Paydas, Arzu Yaren, Deniz Can Guven, Atike Pinar Erdogan, Umut Demirci, Alper Yasar, İbrahim Vedat Bayoglu, Mutlu Hizal, Burcu Gulbagci, Nail Paksoy, Sena Ece Davarci, Funda Yilmaz, Ozlem Dogan, Sibel Oyucu Orhan, Erkan Kayikcioglu, Ali Aytac, Merve Keskinkilic, Eda Eylemer Mocan, Olcun Umit Unal, Esra Aydin, Hakan Yucel, Deniz Isik, Onder Eren, Basak Oyan Uluc, Melike Ozcelik, Ilhan Hacibekiroglu, Adnan Aydiner, Hacer Demir, Berna Oksuzoglu, Ebru Cilbir, Erdem Cubukcu, Bulent Cetin, Esin Oktay, Cihan Erol, Sadi Kerem Okutur, Nilgun Yildirim, Ali Alkan, Fatih Selcukbiricik, Asude Aksoy, Yusuf Karakas, Gulhan Ozkanli, Berna Bozkurt Duman, Dincer Aydin, Ozgecan Dulgar, Muhammed Muhiddin Er, Fatih Teker, Tugba Yavuzsen, Musa Baris Aykan, Ali Inal, Yakup Iriagac, Nurhan Onal Kalkan, Murat Keser, Teoman Sakalar, Serkan Menekse, Engin Kut, Burak Bilgin, Muge Karaoglanoglu, Veli Sunar, Ozlem Ozdemir, Nazim Serdar Turhal, Nuri Karadurmus, Bulent Yalcin, Mehmet Ali Nahit Sendur
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4603b0dea982cdc71feb0666817cb5
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
